Navigation Links
Boston Scientific Announces Schedule for European Society of Cardiology Congress
Date:8/27/2009

NATICK, Mass., Aug. 27 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements for the European Society of Cardiology (ESC) Congress, which runs from August 29 to September 2 in Barcelona. Highlights include final results from the MADIT-CRT trial and two-year results from the SYNTAX trial.

"Boston Scientific is proud to be the exclusive sponsor of the landmark MADIT-CRT trial, and we look forward to the presentation of the final data at ESC," said Ray Elliott, President and Chief Executive Officer of Boston Scientific. "MADIT-CRT is breaking new ground by demonstrating that early intervention with cardiac resynchronization defibrillation therapy (CRT-D) slows the progression of heart failure when compared to standard implantable cardioverter defibrillator (ICD) therapy. We are also looking forward to the presentation of two-year data from our SYNTAX trial, comparing the use of percutaneous coronary intervention (PCI) using the TAXUS(R) Express2(R) Paclitaxel-Eluting Coronary Stent System to coronary artery bypass graft (CABG) surgery in patients with complex disease. We are hopeful these results will build on the one-year data, which showed comparable safety outcomes for PCI and CABG."

Details of the Company's activities at ESC are below.

Schedule of Events (All times are local Barcelona; all events are held at the Fira Gran Via Convention Center.)

Sunday, August 30

  • HORIZONS-AMI Trial Results. One-year data from the HORIZONS-AMI trial will be presented in a poster session at 8:30 a.m. The trial was designed to determine the safety and efficacy of the TAXUS Express2 Paclitaxel-Eluting Coronary Stent Sy
    '/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial
2. Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
3. Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
4. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
5. Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientifics TAXUS(R) Liberte(R) Stent
6. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
7. Clinical Data Reinforce Safety and Efficacy of Boston Scientifics Two Drug- Eluting Stent Platforms
8. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
9. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
10. Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
11. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... LONDON , May 22, 2015 ... early phase clinical research unit with a worldwide ... respected for its frequent publications in peer reviewed ... and European stakeholders and regulators in discussions about ... results.      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , ...
(Date:5/22/2015)... -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ("Nepstar" ... China based on the number ... Mr. Fuxiang Zhang as the Company,s Chief ... Rebecca Yingnan Zhang has been appointed as Chief ... immediately. Meanwhile, Ms. Zhang resigned from the position as ...
(Date:5/21/2015)... , May 21, 2015  When ... along the side of his neck, he ... took a couple weeks off from weight ... go away.                               A ... 26, was referred to Michel Kliot, ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
... 2012  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... fourth quarter and full year financial results for the ... 2012 after market close. PDL,s management will host a ... Eastern Time to discuss the financial results. ...
... 2012  ViroPharma Incorporated (NASDAQ: VPHM ) today ... orphan drug Plenadren ® (hydrocortisone, modified release tablet) ... Metabolism (JCEM), a leading scientific journal for endocrinology. Plenadren ... adrenal insufficiency in adults. The authors described ...
Cached Medicine Technology:PDL BioPharma to Announce Fourth Quarter and Full Year 2011 Financial Results on February 23, 2012 2Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism 2Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism 3Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism 4Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism 5Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism 6
(Date:5/25/2015)... Join Fiona's Soccer Camp at Novato High School's ... Irish National Player, Fiona O'Sullivan will be on site to ... her coaching style. Fiona has three camps running this summer ... at Lynwood Elmentary School (June 15-19) and Hill Recreation Center ... 6th, 2015 - 1:00-3:00pm. Bring a Soccer Ball, Cleats and ...
(Date:5/25/2015)... 2015 Decora Preset 60 Minute Countdown ... available on ‘The Hardware City.’ The product helps in automatically ... a time and the related electronic device is automatically turned ... of the company said, “We are glad that this amazing ... can buy Countdown Timer Switch in just a few clicks. ...
(Date:5/24/2015)... For people who are keen on the Enterokinase ... Research Report would be an useful report to refer ... present market scenario of this industry. The report also ... of this industry. The report summarizes key statistics of ... in this industry. The report is a valuable source ...
(Date:5/24/2015)... May 24, 2015 The federal ... http://www.testosteronelawsuithub.com/ ) has scheduled its next monthly Case ... multidistrict litigation. According to court documents filed in ... the Conference will be convened on June 2, ... Therapy Product Liability Litigation - MDL No. 2545) ...
(Date:5/24/2015)... WI (PRWEB) May 24, 2015 ... Health System CEO - The ... and honored at the fourth annual ... April 15 at Geneva National in ... school): ,     -Badger High School,         Jonathan ...
Breaking Medicine News(10 mins):Health News:US Sports Camps and Nike Soccer Camps Offer Complimentary Instructional Clinic with Fiona's Soccer Camp 2Health News:Leviton's Decora 60 Minute Countdown Timer Available On ‘The Hardware City’ 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2
... million breast cancer survivors have a lifetime risk for ... the limbs and impacts physical and psychosocial health. Second ... most dreaded effect of breast cancer treatment. In a ... risk of developing lymphedema is 40 percent to 60 ...
... which is acupuncture performed by a licensed physician trained ... for pain control. Richard Niemtzow, MD, PhD, MPH, Editor-in-Chief ... www.liebertpub.com/acu ) and the official journal of the American ... these efforts in the military. , The technique ...
... Society has worked out new guidelines for the diagnosis ... Malignant melanoma is responsible for 90% of deaths from ... last 30 years and UV radiation is thought to ... , Claus Garbe of Tbingen University and his ...
... effects our health so what influences our decisions to adopt ... like doctors and counsellors do and say what they do? ... workplace, the internet, and community in which we live be ... with addiction? How can schools promote healthy living? What could ...
... desmoteplase,s poor showing, researchers say , , THURSDAY, Dec. 18 (HealthDay ... of the vampire bat has failed to reduce stroke damage ... called desmoteplase, remains alive, experts say, because the study may ... "The sample size was underpowered to detect any benefit," said ...
... Partner in Madrid, Spain has developed a creative solution of ... encourage discussions between medical professionals. , ... ... Scala , the leading provider of end-to-end solutions for the ...
Cached Medicine News:Health News:Obesity increases lymphedema risk for breast cancer survivors 2Health News:New Year starts with focus on healthy living 2Health News:New Year starts with focus on healthy living 3Health News:Bat Saliva-Based Stroke Drug Disappoints in Trial 2Health News:Bat Saliva-Based Stroke Drug Disappoints in Trial 3Health News:Medical Congresses Employ Interactive Digital Posters to Deliver Dynamic Content to Medical Professionals 2Health News:Medical Congresses Employ Interactive Digital Posters to Deliver Dynamic Content to Medical Professionals 3Health News:Medical Congresses Employ Interactive Digital Posters to Deliver Dynamic Content to Medical Professionals 4Health News:Medical Congresses Employ Interactive Digital Posters to Deliver Dynamic Content to Medical Professionals 5
For the qualitative detection of human Chorionic Gonadotrophin (HCG) in urine or urine and serum specimens...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: